W. Wendell Cheatham

W. Wendell Cheatham

Keine laufenden Positionen mehr
77 Jahre
Health Technology

Profil

W.
Wayman Wendell Cheatham has been Corporate Vice President of MannKind Corp.
since August 2002 and Chief Medical Officer since November 2004.
From April 1999 to August 2002, he was Vice President of Medical & Regulatory Affairs for Takeda Pharmaceuticals North America, Inc. and Director of Medical Affairs for Novo Nordisk Pharmaceuticals North America, Inc. from August 1996 to April 1999.
Currently, Dr. Cheatham is a Director of the American Diabetes Association.
He received an MD from the Pennsylvania State University College of Medicine in 1975.

Ehemalige bekannte Positionen von W. Wendell Cheatham

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Private Unternehmen1

Health Technology

  1. Börse
  2. Insiders
  3. W. Wendell Cheatham